| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.58M | $ 1.90M | $ 85.84K | $ 357.68K | $ 24.23K |
| Gross Profit | $ -2.93M | $ 923.23K | $ -118.31K | $ 18.12K | $ -5.22M |
| Operating Income | $ -3.37M | $ -3.30M | $ -5.25M | $ -12.29M | $ -8.20M |
| EBITDA | $ -2.96M | $ -2.92M | $ -13.30M | $ -5.25M | $ -6.63M |
| Net Income | $ -3.36M | $ -3.46M | $ -13.72M | $ -5.96M | $ -8.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 533.70K | $ 241.42K | $ 895.13K | $ 4.56M | $ 9.94M |
| Total Assets | $ 7.17M | $ 6.77M | $ 7.74M | $ 20.95M | $ 33.57M |
| Total Debt | $ 1.76M | $ 735.60K | $ 147.78K | $ 114.58K | $ 824.00K |
| Net Debt | $ 1.22M | $ 494.18K | $ -747.35K | $ -2.41M | $ -1.07M |
| Total Liabilities | $ 2.92M | $ 1.88M | $ 973.13K | $ 830.31K | $ 9.38M |
| Stockholders' Equity | $ 4.25M | $ 4.89M | $ 6.77M | $ 20.12M | $ 24.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.02M | $ -2.72M | $ -3.60M | $ -5.80M | $ -7.18M |
| Operating Cash Flow | $ -3.02M | $ -2.72M | $ -3.60M | $ -5.73M | $ -6.78M |
| Investing Cash Flow | $ -302.00 | $ 105.76K | $ 2.21M | $ 6.67M | $ 5.59M |
| Financing Cash Flow | $ 3.31M | $ 1.95M | $ -94.78K | $ -120.38K | $ -208.64K |
Rua Bioscience Ltd. (NZ:RUA)
:RUA
